DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Share Price

Certificat

DE000ME9Z5V8

Market Closed - Börse Stuttgart 17:12:57 31/05/2024 BST
5.48 EUR +3.98% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-13.84%
1 month-13.84%
Date Price Change
31/05/24 5.48 +3.98%
30/05/24 5.27 +3.54%
29/05/24 5.09 +64.72%
28/05/24 3.09 -8.58%
24/05/24 3.38 -4.25%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 05:12 pm

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME9Z5V
ISINDE000ME9Z5V8
Date issued 08/03/2024
Strike 85 $
Maturity 20/09/2024 (112 Days)
Parity 1 : 1
Emission price 4.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.54
Lowest since issue 3.09
Spread 0.08
Spread %1.52%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
79.98 USD
Average target price
90.35 USD
Spread / Average Target
+12.97%
Consensus